LYELL IMMUNOPHARMA
HQ - San Francisco, California
Summary
Lyell Immunopharma is a clinical-stage biotechnology company focused on developing CAR T-cell therapies for cancer treatment.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 205 M
Avg. Deal Size£ 102 M
All rights reserved. Copyright © 2026 Datasite
